MOXD1
DBH-like monooxygenase protein 1
Also known as: dJ248E1.1, DKFZP564G202, MOX, MOXD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UVY6
- Gene
- MOXD1
- Ensembl
- ENSG00000079931
- Chromosome
- 6
- Canonical length
- 613 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable copper ion binding activity and dopamine beta-monooxygenase activity. Predicted to be involved in dopamine catabolic process; norepinephrine biosynthetic process; and octopamine biosynthetic process. Part of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
613 residues, UniProt reviewed canonical sequence.
>Q6UVY6|MOXD1
1 MCCWPLLLLW GLLPGTAAGG SGRTYPHRTL LDSEGKYWLG WSQRGSQIAF RLQVRTAGYV
61 GFGFSPTGAM ASADIVVGGV AHGRPYLQDY FTNANRELKK DAQQDYHLEY AMENSTHTII
121 EFTRELHTCD INDKSITDST VRVIWAYHHE DAGEAGPKYH DSNRGTKSLR LLNPEKTSVL
181 STALPYFDLV NQDVPIPNKD TTYWCQMFKI PVFQEKHHVI KVEPVIQRGH ESLVHHILLY
241 QCSNNFNDSV LESGHECYHP NMPDAFLTCE TVIFAWAIGG EGFSYPPHVG LSLGTPLDPH
301 YVLLEVHYDN PTYEEGLIDN SGLRLFYTMD IRKYDAGVIE AGLWVSLFHT IPPGMPEFQS
361 EGHCTLECLE EALEAEKPSG IHVFAVLLHA HLAGRGIRLR HFRKGKEMKL LAYDDDFDFN
421 FQEFQYLKEE QTILPGDNLI TECRYNTKDR AEMTWGGLST RSEMCLSYLL YYPRINLTRC
481 ASIPDIMEQL QFIGVKEIYR PVTTWPFIIK SPKQYKNLSF MDAMNKFKWT KKEGLSFNKL
541 VLSLPVNVRC SKTDNAEWSI QGMTALPPDI ERPYKAEPLV CGTSSSSSLH RDFSINLLVC
601 LLLLSCTLST KSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MOXD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- smooth muscle: 74 nTPM
- endometrium: 60 nTPM
- kidney: 38 nTPM
- seminal vesicle: 37 nTPM
- adrenal gland: 34 nTPM
- prostate: 30 nTPM
Single-cell type
- pituicytes/fscs: 262 nCPM
- decidual stromal cells: 133 nCPM
- salivary myoepithelial cells: 131 nCPM
- early spermatids: 128 nCPM
- endometrial stromal cells: 96 nCPM
- esophageal basal cells: 93 nCPM
Immune cell
- plasmacytoid DC: 5.1 nTPM
- memory B-cell: 3.1 nTPM
- naive B-cell: 1.7 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- amygdala: 32 nTPM
- cerebral cortex: 19 nTPM
- white matter: 17 nTPM
- hippocampal formation: 16 nTPM
- basal ganglia: 15 nTPM
- thalamus: 8.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.54
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Copper type II, ascorbate-dependent monooxygenase, N-terminal
- Dopamine beta-hydroxylase-like
- DOMON domain
- PHM/PNGase F domain superfamily
- Copper type II, ascorbate-dependent monooxygenase-like, C-terminal
- Copper type II ascorbate-dependent monooxygenase, C-terminal
- Tyramine beta-hydroxylase/Dopamine beta-hydroxylase
- Copper type II, ascorbate-dependent monooxygenase, N-terminal domain superfamily
- Copper-dependent monooxygenases, DOMON domain
- Copper type II ascorbate-dependent monooxygenase, N-terminal domain
- DOMON domain
- Copper type II ascorbate-dependent monooxygenase, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MOXD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MOXD1 as an antibody target. Whether an autoantibody or antibody against MOXD1 could matter depends on whether native MOXD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MOXD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MOXD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...